Patrick G Lepore's Net Worth
$15.2 Million
Who is Patrick G Lepore?
Patrick G Lepore has an estimated net worth of $15.2 Million. This is based on reported shares across multiple companies, which include PharMerica CORP, Innoviva, Inc., Matinas BioPharma Holdings, Inc., VYNE Therapeutics Inc., LANNETT CO INC, PAR PHARMACEUTICAL COMPANIES, INC., and Vyteris Holdings (Nevada), Inc..
SEC CIK
Patrick G Lepore's CIK is 0001055404
Past Insider Trading and Trends
2019 was Patrick G Lepore's most active year for acquiring shares with 8 total transactions. Patrick G Lepore's most active month to acquire stocks was the month of December. 2011 was Patrick G Lepore's most active year for disposing of shares, totalling 29 transactions. Patrick G Lepore's most active month to dispose stocks was the month of April. 2007 saw Patrick G Lepore paying a total of $2,400,000.00 for 233,800 shares, this is the most they've acquired in one year. In 2012 Patrick G Lepore cashed out on 630,678 shares for a total of $23,928,742.88, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PharMerica CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -29.57K |
$29.25 | -$864,922.50 |
0
|
Dec 7
| |||
Form 4
| +19.46% | 4.82K |
—
|
—
| 29.57K |
Jun 14
| |||
Form 4
| +26.38% | 5.17K |
—
|
—
| 24.75K |
Jun 17
| |||
Form 4
| +23.52% | 3.73K |
—
|
—
| 19.59K |
Jun 19
| |||
Form 4
| +37.21% | 4.3K |
—
|
—
| 15.86K |
Jun 17
| |||
Form 4/A
| +92.60% | 5.56K |
—
|
—
| 11.56K |
Jun 18
| |||
Form 4
| +94.75% | 5.68K |
—
|
—
| 11.69K |
Jun 17
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Innoviva, Inc. (INVA) Snapshot price: $18.7201
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +51.68% | 19.86K |
—
|
—
| 58.28K |
Apr 20
| |||
Form 4
|
∞
| 38.42K |
—
|
—
| 38.42K |
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Matinas BioPharma Holdings, Inc. (MTNB) Snapshot price: $3.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| +33.33% | 100K |
$0.73 | $73,050.00 | 400K |
May 14
| |||
Form 4
| +50.00% | 100K |
$1.06 | $105,530.00 | 300K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +100.00% | 100K |
$0.72 | $71,850.00 | 200K |
Aug 16
| |||
Form 4
|
∞
| 100K |
$0.95 | $95,250.00 | 100K |
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VYNE Therapeutics Inc. (VYNE) Snapshot price: $1.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
| +55.39% | 13K |
$3.91 | $50,778.00 | 36.47K |
Nov 15
| |||
Form 4
| +576.04% | 20K |
$2.48 | $49,680.00 | 23.47K |
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LANNETT CO INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.53% | 100K |
$0.49 | $49,000.00 | 587.14K |
Nov 10
| |||
Form 4
| +11.44% | 50K |
$0.54 | $27,000.00 | 487.14K |
May 16
| |||
Form 4
| +12.92% | 50K |
$0.88 | $44,000.00 | 437.14K |
Feb 8
| |||
Form 4
| +14.83% | 50K |
$1.71 | $85,500.00 | 387.14K |
Nov 29
| |||
Form 4
| +6.31% | 20K |
$3.31 | $66,200.00 | 337.14K |
Sep 8
| |||
Form 4
| +21.83% | 56.82K |
—
|
—
| 317.14K |
Aug 31
| |||
Form 4
| +8.32% | 20K |
$4.18 | $83,600.00 | 260.33K |
May 11
| |||
Form 4
| +19.36% | 38.99K |
—
|
—
| 240.33K |
Sep 1
| |||
Form 4
| +14.18% | 25K |
$9.82 | $245,500.00 | 201.34K |
Sep 3
| |||
Form 4
| +23.41% | 33.45K |
—
|
—
| 176.34K |
Jul 19
| |||
Form 4
| +21.21% | 25K |
$7.32 | $183,000.00 | 142.9K |
May 8
| |||
Form 4
| +26.91% | 25K |
$8.93 | $223,250.00 | 117.89K |
Feb 12
| |||
Form 4
| +36.82% | 25K |
$5.10 | $127,500.00 | 92.89K |
Dec 13
| |||
Form 4
| +58.28% | 25K |
$5.34 | $133,500.00 | 67.89K |
Aug 31
| |||
Form 4
| +60.66% | 16.2K |
—
|
—
| 42.9K |
Jul 20
| |||
Form 4
| +1,470.59% | 25K |
$15.13 | $378,250.00 | 26.7K |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||